Current knowledge on the roles of ERAP1 and ERAP2 in the human immune response have gradually led to the maturation of the hypothesis that the naturally occurring polymorphic variation in ERAP1 and ERAP2 may play significant roles in the pre-disposition to certain cancers, as well as their progression and prognosis. This evidence concerns the gene ERAP1 and cancer.